USA - NASDAQ:SELB - US8162121045 - Common Stock
ChartMill assigns a Buy % Consensus number of 82% to SELB. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-08-18 | Mizuho | Maintains | Buy -> Buy |
| 2023-08-18 | Needham | Maintains | Buy -> Buy |
| 2023-08-18 | SVB Leerink | Downgrade | Outperform -> Market Perform |
| 2023-08-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-08 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-05-05 | Needham | Reiterate | Buy |
| 2023-04-13 | Needham | Reiterate | Buy |
| 2023-03-22 | Mizuho | Maintains | Buy |
| 2023-03-22 | HC Wainwright & Co. | Maintains | Buy |
| 2023-03-21 | Needham | Reiterate | Buy |
| 2023-03-03 | Needham | Reiterate | Buy |
| 2023-01-31 | Canaccord Genuity | Maintains | Buy |
| 2022-06-21 | HC Wainwright & Co. | Maintains | Buy |
| 2022-06-14 | Needham | Maintains | Buy |
| 2022-06-06 | SVB Leerink | Initiate | Outperform |
| 2022-05-06 | Needham | Maintains | Buy |
| 2021-11-01 | Needham | Maintains | Buy |
| 2021-06-15 | BTIG | Initiate | Buy |
| 2021-03-12 | William Blair | Upgrade | Market Perform -> Outperform |
12 analysts have analysed SELB and the average price target is 3.57 USD. This implies a price increase of 305.13% is expected in the next year compared to the current price of 0.8812.
The consensus rating for SELECTA BIOSCIENCES INC (SELB) is 81.6667 / 100 . This indicates that analysts generally have a positive outlook on the stock.